Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021

NEXT STORY
Codiak to Present Preclinical Data Demonstrating Broad Potential Applications for Engineered Exosomes at the American Society for Gene and Cell Therapy (ASGCT) Annual Meeting
PREV STORY
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OPEP Device For COPD Symptom Relief – AirPhysio Lung Expansion Product Launched

author_avatar
NASDAQ Market News

Pain Management Devices Market Research Report by Product, by Application, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News

CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia  

author_avatar
NASDAQ Market News